• Establish and maintain strategic business relationships with national, regional, and local dermatology and allergy experts.• Collaborate with national account managers, marketing, and healthcare provider experts to assist with disease awareness, product expertise, and the improvement of product access for appropriate patients within approved labeling.• Coordinate and lead the development of synergies with regional congresses/meetings/symposia, as well as, related national congresses (AAD, AAAAI, AOCD, Maui Derm, Fall Clinical, CDNPPA, etc.)

• Establish and maintain strategic business relationships with national, regional, and local cardiovascular experts in aligned geography of Tennessee, Ohio, and Kentucky.• Collaborate with national account managers, marketing and healthcare provider experts to assist with disease awareness, product expertise, and the improvement of product access for appropriate patients within approved labeling.• Attend and lead the development of synergies with regional congresses/meetings/symposia, as well as, related national congresses (ACC, AHA, NLA, ADA, etc)

• 2016 - Ranked #1 nationally out of 60• 2016 - Ranked #2 in the district for Spring Contest • 2015 - Top 20% nationally out of 60 YTD• 2015 - Won 5 out of 5 months for "Launch Breadth Contest" to increase number of new HCPs prescribing for appropriate patients within approved labeling.• Developed strategy and tactics within key accounts for responsible brands in a way that brings value to the patient, the physician/health-system and Regeneron.• Collaborated across a broad matrix team with a focus on Health-System owned Cardiologists, Endocrinologists, Fellows, Residents and Hospitalists.• Successfully launched first in class subcutaneous monoclonal antibody (alirocumab), a PCSK9 inhibitor, for the management of LDL cholesterol for patients not able to reach goal on standard of care within appropriate, approved labeling.Key Health Systems/Hospitals: Vanderbilt, HCA, Ascension, Tennova, Covenant, TriStar, Saint Thomas, Baptist Health, University of Tennessee, and Blount Memorial.

Significantly increased sales growth of IV Biologic and built/utilized relationships within Academics, high volume Rheumatology clinics, and under-performing Rheumatology practices. One of four Account Executives promoted nationwide to newly created position to work with local Account Specialists. Provided leadership to cross-functional groups including Payer Relations, Marketing, Business Plan Development, Field Sales, Engagement Plans, and VP Council. Key Accounts include Vanderbilt, UAB, and Ochsner IDN.1. Increasing product education and sales penetration within academics, IDN's, and key private accounts regarding an infused biologic for systemic lupus erythematosus.2. Creating appropriate needs for buy and bill customers and leveraging matrix resources.3. Educating infusion nurses and pharmacy on proper dosing and administration.4. Informing and delivering resources to HCPs, nurses and benefit investigators to potentially aid patient access to product.5. Developing and implementing regional strategic business plans.6. Executing needs analysis for academic, IDN and private accounts.

Significantly increased sales growth of COPD/asthma portfolio, IV anticoagulant, and psoriasis medicine while building relationships within military treatment facilities (MTFs) and VA Hospitals. Provided leadership to cross-functional groups including Marketing, Field Sales, and Change Plans. Key accounts included Fort Knox, Fort Campbell, Redstone Arsenal (Huntsville), Memphis VA, Nashville VA, and VISN 9.1. Grew sales of respiratory, dermatology, and IV cardiovascular products within DoD and VA.2. Created collaborative Tricare marketing strategy between hospital and field sales. Gained second line leadership approval. Strategy subsequently executed nationally. 3. Increased growth for Heparin-Induced Thrombocytopenia IV drug within VA Hospitals. Educated ICU nurses on disease/proper administration.4. Increased growth of psoriasis medicine within VA Hospitals. Educated providers, nurses, and pharmacists about information for patients.5. Gained support from internal/external stakeholders to execute on strategic priorities.6. Obtained admittance to see key customers within difficult to access military accounts.7. Significantly improved Tricare share within community and increased sales volume within military treatment facilities (MTFs).

1. Exceeded sales target 18 of 21 quarters.2. Created, educated and executed sample allocation strategy that directly aided attainment of sales targets.3. Grew sales of respiratory products for pulmonologists, allergists and primary care.

Delivered significantly increased sales volume growth of COPD, asthma, and migraine portfolio. Migraine portfolio included subcutaneous injection. Provided leadership to Regional, Sector, and Marketing Advisory Boards, PAC Board of Directors, Associate Trainers, and New Hires.1. Created novel sample management algorithm to increase sales while decreasing the utilization of product samples. 2. Created and executed Adherence Pilot Project for South Alabama District to help keep appropriate patients on product. Secured approval and resources from Marketing. 3. Preserved positive product formulary presence at St. Vincent's and Brookwood hospitals.

Significantly improved market share of anti-infective. Significantly increased market share of ACE and CCB/ACE products. District trainer.

Contract sales force for Abbott. Top 20% hired as Abbott employees after six month contract.